Evaluating the risk-benefit ratio of adjuvant trastuzumab-based therapy for T1a,bN0M0 HER2-positive breast carcinomas

被引：4
|
作者：
Rodrigues, M. J. [1 ,2 ]
Albiges-Sauvin, L. [2 ,3 ]
Wassermann, J. [2 ,4 ]
Cottu, P. H. [1 ]
机构：
[1] Inst Curie, Dept Med Oncol, Paris, France
[2] AERIO, Paris, France
[3] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France
[4] Hop Rene Huguenin, Inst Curie, Dept Med Oncol, St Cloud, France
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷 / 11期
关键词：
CANCER;
D O I：
10.1093/annonc/mdr308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2530 / 2530
页数：1
相关论文
共 50 条
  • [1] Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study
    Ali, Sanji
    Hendry, Jace
    Le, Duc
    Mondal, Prosanta K.
    Sami, Amer
    Chalchal, Haji
    Haider, Kamal
    Ahmed, Osama
    El-Gayed, Ali
    Wright, Philip
    Pauls, Mehrnoosh
    Johnson, Kate
    Ahmed, Shahid
    [J]. SCIENTIFIC REPORTS, 2022, 12 (01)
  • [2] Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study
    Sanji Ali
    Jace Hendry
    Duc Le
    Prosanta K. Mondal
    Amer Sami
    Haji Chalchal
    Kamal Haider
    Osama Ahmed
    Ali El-Gayed
    Philip Wright
    Mehrnoosh Pauls
    Kate Johnson
    Shahid Ahmed
    [J]. Scientific Reports, 12
  • [3] Outcomes of women HER2 positive T1a/bN0M0 breast cancer treated with adjuvant trastuzumab: A retrospective population-based cohort study
    Hendry, J.
    Ali, S.
    Ahmed, O.
    Chalchal, H.
    El-Gayed, A.
    Haider, K.
    Iqbal, N.
    Johnson, K.
    Le, D.
    Maas, B.
    Manna, M.
    Pauls, M.
    Salim, M.
    Sami, A.
    Wright, P.
    Younis, M.
    Ahmed, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S45 - S46
  • [4] Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?
    Kelly, C. M.
    Pritchard, K. I.
    Trudeau, M.
    Andreopoulou, E.
    Hess, K.
    Pusztai, L.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (11) : 2387 - 2393
  • [5] Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors
    Rakkhit, R.
    Broglio, K.
    Peintinger, F.
    Cardoso, F.
    Hanrahan, E. O.
    Litton, J. K.
    Sahin, A.
    Larsimont, D.
    Meric-Bernstam, F.
    Buchholz, T. A.
    Valero, V.
    Theriault, R. L.
    Piccart, M.
    Ravdin, P.
    Hortobagyi, G. N.
    Gonzalez-Angulo, A. M.
    [J]. CANCER RESEARCH, 2009, 69 (02) : 98S - 98S
  • [6] Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
    Shinsuke Sasada
    Naoto Kondo
    Hiroya Hashimoto
    Yuko Takahashi
    Kaori Terata
    Kumiko Kida
    Yasuaki Sagara
    Takayuki Ueno
    Keisei Anan
    Akihiko Suto
    Chizuko Kanbayashi
    Mina Takahashi
    Rikiya Nakamura
    Toshiyuki Ishiba
    Michiko Tsuneizumi
    Seiichiro Nishimura
    Yoichi Naito
    Fumikata Hara
    Tadahiko Shien
    Hiroji Iwata
    [J]. Breast Cancer Research and Treatment, 2023, 202 : 473 - 483
  • [7] Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer
    Sasada, Shinsuke
    Kondo, Naoto
    Hashimoto, Hiroya
    Takahashi, Yuko
    Terata, Kaori
    Kida, Kumiko
    Sagara, Yasuaki
    Ueno, Takayuki
    Anan, Keisei
    Suto, Akihiko
    Kanbayashi, Chizuko
    Takahashi, Mina
    Nakamura, Rikiya
    Ishiba, Toshiyuki
    Tsuneizumi, Michiko
    Nishimura, Seiichiro
    Naito, Yoichi
    Hara, Fumikata
    Shien, Tadahiko
    Iwata, Hiroji
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 202 (03) : 473 - 483
  • [8] Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a/bN0M0 breast cancer.
    Takahashi, Yuko
    Sasada, Shinsuke
    Kondo, Naoto
    Hashimoto, Hiroya
    Terata, Kaori
    Sagara, Yasuaki
    Naito, Yoichi
    Kida, Kumiko
    Ueno, Takayuki
    Anan, Keisei
    Suto, Akihiko
    Kanbayashi, Chizuko
    Takahashi, Mina
    Nakamura, Rikiya
    Ishiba, Toshiyuki
    Tsuneizumi, Michiko
    Nishimura, Seiichiro
    Hara, Fumikata
    Shien, Tadahiko
    Iwata, Hiroji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Adjuvant treatment with trastuzumab of patients with HER2-positive, T1a-bN0M0 breast tumors: A systematic review and meta-analysis
    Hassing, Christina M. S.
    Nielsen, Dorte Lisbet
    Knoop, Ann Soegaard
    Tvedskov, Tove Holst Filtenborg
    Kroman, Niels
    Laenkholm, Anne-Vibeke
    Juhl, Carsten Bogh
    Kuemler, Iben
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 184
  • [10] Adjuvant chemotherapy in T1a/bN0 HER2-positive or triple-negative breast cancers: Application and outcomes
    Migdady, Yazan
    Sakr, Bachir J.
    Sikov, William M.
    Olszewski, Adam J.
    [J]. BREAST, 2013, 22 (05): : 793 - 798
12345